However, as the central molecule in our network (Fig. 3B), communicating with DELTA133P53, CCNE1 and STAT3, AGO2 may mediate cross-talk between adiposity, weight loss and CRC risk with inflammation as the potential causal pathway (Fig. 5). This evidence concerns the gene AGO2 and colorectal carcinoma.